The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

AIM Rule 17 Disclosure

10 Aug 2020 16:43

RNS Number : 6993V
Brooks Macdonald Group PLC
10 August 2020
 

Brooks Macdonald Group plc

(the "Company")

 

AIM Rule 17 Disclosure

 

On 6 August 2020 Artemis Investment Management LLP notified the Company that its percentage holding in the ordinary shares of the Company, with a nominal value of 1 pence each ("Ordinary Shares"), became 6.78% on 5 August 2020, after it had sold certain Ordinary Shares.

 

The Company are therefore announcing this information in order to comply with Rule 17 of the AIM Rules for Companies.

 

 

Enquiries:

 

Brooks Macdonald Group PLC

Caroline Connellan, Chief Executive

+44 (0)20 7659 3492

Ben Thorpe, Group Finance Director

+44 (0)20 7659 3492

Peel Hunt LLP

Adrian Trimmings / John Welch / Rishi Shah

+44 (0)20 7418 8900

 

LEI: 213800WRDF8LB8MIEX37

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCKKKBQPBKDBFD

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.